Short Term Complications Of Intravitreal Injection Of Bevacizumab.

Authors: Khan Mohammad Nangrejo, Amjad Ali Sahto, Shahid Jamal Siddique, Muhammad Afzal Pechuho.

PEOPLES UNIVERSITY OF MEDICAL & HEALTH SCIENCE NAWABSHAH (SBA)
PEOPLES UNIVERSITY OF MEDICAL & HEALTH SCIENCE NAWABSHAH (SBA)
CHANDKA MEDICAL COLLEGE (SMBBMU) LARKANA.
CHANDKA MEDICAL COLLEGE (SMBBMU) LARKANA.

Volume 17 | Issue 4

Published: November 14, 2026

Abstract

To evaluate the rate of complications after intravitreal injection of Bevacizumab(Avastin). Design: Hospital Based Multicentre Prospective Study. Place: Ophthalmology Department People,s University of Medical & Health Sciences Nawabshah(SBA) and Shaheed Mohtarma Banazeer Bhutto Medical University Larkana.
Duration:Two years period from August 2008 to August 2010 Materials and Methods: The clinical interventional case-series study included 200 intravitreal injections of about 1.25mg bevacizumab, performed in the period from August 2008 to August 2010 by four surgeons at Department of Ophthalmology, Peoples Medical University & Health Science College Nawabshah(SBA) and Shaheed Mohtarma Benazir Bhutto Medical University for patients who were diagnosed to have macular oedema or retinal neovascular disease . Patients were followed for 3 months after injection. Results: Painless vitreous haze was observed in one eye (1/200 or 0.5%) from the bevacizumab injection , Chemosis in 2 cases (2/200 or 1%) and one eye (1/200 or 0.5%) showed rapidly progressive lenticular changes. The total rate of these complicatios was 4/200 (2.00%). Conclusion: Our study shows that the beneficial effectiveness of the drug overwhelms the adverse effects, which are themselves unrelated to the chemical composition of Bevacizumab(Avastin).

Keywords: Bevacizumab, intravitreal injection, Vitreous haze

DOI: (All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.)

Download Full Text PDF